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This paper describes the fundamental mechanisms of microbial contamination during manufacture
of pharmaceutical products. Models are derived that describe air and surface contact contamination.
These models can be used to develop and improve methods of microbial risk assessment. The use of
the FMEA (FMECA) method of risk assessment is discussed and, when used with the correct risk
factors, its use endorsed.
Introduction
The risk to a pharmaceutical product from microbial
contamination must be controlled. Control methods, such as
the use of aseptic manipulation techniques, cleanroom
clothing and appropriate ventilation, are well-established and
described in documents issued by the Regulatory
Authorities1. However, there has been a recent interest in risk
management systems. ISO 14698-12 requires the use of a
formal risk management system to control microbial
contamination. The FDA has recently issued a document
advocating a greater use of risk assessment systems3.
A number of systems exist for managing risk during
manufacturing. These include Fault Tree Analysis (FTA)4,
Failure Mode and Effect Analysis (FMEA)5, Hazard and
Operational Studies (HAZOP)6, and Hazard Analysis and
Critical Control Point (HACCP)7,8. The first three systems
were produced for the electrical and mechanical industries,
but can be used in aspects of pharmaceutical production such
as safety, reliability, and validation. However, they have been
little used in assessing microbial risk to the product, although
a FMEA method has been suggested9, and its use is gaining
popularity10.
The HACCP system was developed for use in the food
industry and is more easily applied in the pharmaceutical
industry, as it uses principles familiar to those working there,
and also considers control and monitoring methods as
important parts of its system. If adapted for use in the
pharmaceutical industry, the HACCP system offers a
systematic way of assessing, controlling, and monitoring
microbial risk11.
All risk systems manage risk in a similar way, an important
component being risk assessment, which calculates or assigns
a degree of risk to a hazard. For a risk management system to
work well, the risk assessment method must accurately
estimate the degree of risk. To ensure this occurs, accurate
models are required that define the actual variables governing
the process and show how these variables must combine to
correctly predict risk. If such models are available, microbial
risk can be assessed by combining the best choice of risk
factors, in the correct way. This paper derives such models.
Fundamental microbial transfer model
The chance of microorganisms being transferred from a
source to a product is dependent on the likelihood of them
being dispersed, transmitted and deposited onto a product. To
calculate the number of microorganisms that would be
deposited during pharmaceutical production, as shown on
Figure 1, onto a given area of product in a given time,
Equation 1 has been derived. This equation is universally
applicable to all sources and routes.
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Figure 1. Transfer of microorganisms from source to product.
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Equation 2
Number of microorganisms deposited by surface contact
(no.) = microbes on contacting surface (no./cm2) ×
transfer coefficient × area of product that is contacted
(cm2) × frequency of contact over the given time
where: 
the ‘transfer coefficient’ is the proportion of microorganisms on a
contaminating surface that is transferred to the product.
A practical example, shown in Figure 2, would be the
contact of a contaminated gloved hand with a product,
where the number of microbes transferred could be
calculated from:
(a) the concentration of microorganisms on the glove
surface;
(b) the proportion of microorganisms on the glove
surface that are transferred to the product i.e. transfer
coefficient;
(c) the area of the product that is touched and; 
(d) the frequency of touching the product surface in the
given time. 
Unfortunately, all of the information required to solve this
equation is seldom available, especially values for the
‘transfer coefficient’ and the ‘frequency of contact’ with
the product. However, the main object of deriving this
equation is to provide the correct contamination model on
which a risk assessment method can be based.
Deposition of microorganisms by airborne route 
Most of the microbe carrying particles in the cleanroom
air come from the skin of personnel. People shed
approximately 109 skin cells per day12, these skin cells
being approximately 33µm × 44 µm12, and are found in
the cleanroom either as whole cells or fragments. A
proportion of these skin cells contains microorganisms,
and cleanroom personnel can disperse through cleanroom
clothing several hundred microbe carrying particles per
minute13. For these reasons, microorganisms are normally
found in cleanrooms attached to skin particles (or very
occasionally a clothing fibre). There is a spectrum of sizes
to be found in the cleanroom air, but the average size,
expressed as an equivalent particle diameter, is similar to
Equation 1
No. of microbes deposited on a product = C ×S ×Pd×Pa×A ×T
where:
C = concentration of microbial contamination on, or in, a source
(number/cm2 for a surface, or number/cm3 for air);
S = the quantity of surface material, or air, that is dispersed, from a
source in a given time (cm2 /s for surfaces, and cm3 /s for air
dispersion); this can also be expressed as the quantity dispersed
per frequency of occurrence;
Pd = proportion of microorganisms dispersed from a source that are
transferred to the area adjacent to the product;
P
a
= proportion of microorganisms in the adjacent area that are
deposited per unit area of the product (/cm2);
A = area of surface onto which microbes are deposit (cm2);
T = time, during which transfers occur (s); this can also be expressed
as frequency of occurrence.
A practical example of the mechanisms described in
Equation 1 would be the airborne transfer of skin
microorganisms from personnel to a product. Here, the
number of microorganisms that would deposit on a
product would depend on: 
(a) the concentration of microorganisms on personnel's
skin surface; 
(b) the surface area of the skin that is dispersed in a given
time; 
(c) the proportion of microorganisms dispersed that are
able to pass through cleanroom clothing and
transverse the air space to the area adjacent to the
product (this is dependent on control measures); 
(d) the proportion of microorganisms adjacent to product
that would be deposited from the air in a given time
onto a given area of exposed product; and 
(e) the time over which this deposition occurs.
Derived deposition models
Equation 1 is a fundamental equation that governs
deposition of microbes onto, or into, a product from all
sources, and by all routes. However, in a cleanroom, the
two main routes of microbial contamination are air
deposition and surface contact, and it is important both
from a theoretical and practical point of view to keep these
two routes separate. Contamination by the liquid route is
another possibility not considered here, but, if required, an
analogous equation to that derived for airborne deposition
can be used. Equations are now developed for the two
main routes of contamination i.e. contact routes and air
deposition.
Deposition of microorganisms by surface
contact
An equation that will calculate the number of
microorganisms deposited by surface contact can be
derived from the fundamental Equation 1 by combining
the dispersion, transfer and deposition variables into one
overall term i.e. ‘transfer coefficient’. Thus, Equation 1
can be reformatted to the following Equation 2 that
calculates the number of microbes deposited on a given
area of product in a given time.
Figure 2.Mechanism of surface contact transfer.
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skin cells. Owing to skin cell fragmentation, and the
varying effect of the filtering action of cleanroom clothing
and ventilation, the average size of microbe carrying
particles will vary between about 8µm and 20µm14, 15, 16,
this size often increasing as the rate of ventilation increases.
These sizes of particles have quite high deposition
velocities of between 0.2cm/s and 3cm/s, the deposition
velocity being the velocity that microbe carrying particles
in the air will deposit into, or onto, the product.
The mechanism of airborne deposition is illustrated in
Figure 3 and expressed mathematically in Equation 3,
where the number of airborne microbes deposited on a
given area over a given time can be calculated. Equation 3
is derived by combining the first three components of
Equation 1 to give the concentration of microorganisms
found adjacent to the product. This is a useful approach, as
this is a value measured in the cleanroom by volumetric air
sampling. The proportion deposited can then be calculated
from knowledge of the deposition velocity, using a time
component expressed as the time the product is exposed to
airborne contamination.
Equation 3
Number of airborne microorganisms deposited onto the
product (no.) = airborne microbial count (number/cm3) ×
deposition velocity of microbes from air (cm/s) x area of
product exposed (cm2) × time of exposure (s)
To solve Equation 3 it is necessary to know the
deposition velocity of the microbe carrying particles in the
air surrounding the product. This is generally unknown,
although it can be calculated from a knowledge of the
volumetric and settle plate counts16. However, by
combining the first two variables, Equation 3 can be
simplified to the following:
Equation 4
Number of airborne microorganisms deposited onto the
product in a given time (no.) = Deposition rate
(no./(cm2.s)) × area of product exposed (cm2) × time of
exposure (s)
Settle plates exposed adjacent to the product give the
number of microbe carrying particles that deposit onto a
known area of settle plate exposed for a given time. This
information can be easily recalculated as a deposition rate
of no./(cm2.s). The likely number of airborne
microorganisms that will deposit onto a product can then
be calculated.
Equations 2 and 4 are the best equations to use to
calculate the amount of surface contact or airborne
deposition onto a pharmaceutical product. If numerical
values e.g. microbial concentrations, or the number of
times a product is touched, are available to substitute into
the equations, then the most accurate solution can be
obtained. However, numerical values required to
mathematically solve Equation 2 for surface contact are
generally unavailable, although those required for the
airborne deposition equation should be available. If they
are not, then a solution can be found by substituting risk
descriptors. These risk descriptors are surrogates for the
actual numerical values and are often verbal descriptors of
risk e.g. ‘high’, ‘medium’ and ‘low’. Both numerical
values and risk descriptors should be chosen from the
information available to best reflect the required equation
variables and their relative importance to each other. How
this might be done is described in a further article in this
journal17.
Correlation of the contamination models
with criticality risk assessment
The Failure Mode and Effect Analysis (FMEA) method
has been in use since the late 1940s, but in 1985 the
International Electronic Commission published a report
on a procedure for Failure Mode and Effect Analysis
(FMEA)5. This report, which has the status of an ISO
standard, is considered to describe the definitive method
of FMEA. The report also includes a description of Failure
Mode and Effect and Criticality Analysis (FMECA) that
incorporates a method for assessing the ‘criticality’ of
risk.  In this, risk is defined by two components, namely,
its ‘criticality’ and ‘frequency’ of occurrence. Criticality
may be considered to be the degree of risk from an
undesirable event i.e. its undesirability or importance.
Frequency can be considered as the number of times an
event occurs, or the length of time over which it occurs.
This concept is shown graphically in Figure 4, where it
can be seen that as the ‘criticality’ and ‘frequency’ of
occurrence increases, either separately or in combination,
the risk will increase.
Risk may be defined mathematically in Equation 5.
Equation 5
Risk = criticality of the occurrence × frequency of occurrence
To use Equation 5 to assess risk from microbial
contamination requires a definition of the words
‘frequency’ and ‘criticality’, as interpretation of the
meaning of these words varies between manufacturing
industries and applications. In the previous sections of this
paper, the fundamental equations that predict the
microbial contamination of a product were derived. TheseFigure 3.Mechanism of airborne deposition
Airborne micro-
organisms/cm3
Deposition velocity
(cm/s)
Surface contaminated (cm2)
14 W WHYTE AND T EATON
equations show that the amount of microbial
contamination is dependent on:
(a) the concentration of microorganisms on a
contaminating surface, or within air; 
(b) how much of this contamination is dispersed and
transferred to the area next to the product; 
(c) how much is deposited onto the product and; 
(d) a variable of time. 
A combination of the variables ‘a’, ‘b’ and ‘c’, should be
considered to express ‘criticality’ in terms of microbial
contamination, i.e. the likelihood that microbes will be
dispersed, transferred and deposited onto the product. If
the time is taken as the time available for contamination to
occur, or the frequency of an occurrence of contamination,
then it may be seen that Equation 5 is, in essence, the
same as the fundamental equations of microbial
contamination derived in this paper. The correctness of
the use of the FMECA criticality risk assessment method
when working with microbial contamination is thus
clarified and, when used with the correct risk factors, its
use endorsed.
Choosing the correct microbial risk
assessment model
The Failure Mode and Effect Analysis (FMEA) method of
risk assessment, as outlined by Keiffer9, has been gaining
popularity10, and is used in safety, reliability, and
validation, as well as in microbiological contamination.
Although this method is called FMEA in the Keiffer paper
it would be considered a Failure Mode and Effect and
Criticality Analysis (FMECA) method in the IEC
document. It is considered by Keiffer that:
Equation 6
Risk (priority number) = probability × severity ×
likelihood of detection
Equation 6 is similar to Equation 5 in that ‘probability’
can be considered to be ‘frequency’ and ‘severity’ to be
‘criticality’, but there is an additional third variable of
‘detection’. A risk assessment based on Equation 6, and
using a third additional variable of ‘detection’, works well
in aspects of engineering manufacturing such as reliability
of electronic goods, where ‘detection’ of a faulty circuit is
clearly relevant to the likelihood of identifying the
breakdown of the product. It is also useful in controlling
non microbiological aspects of pharmaceutical
production, and by measuring pH, optical properties,
weight etc. faults in the process can be detected and the
risk reduced. However, it is not possible to ‘detect’
microbial contamination of a product during manufacture.
Even if this was possible, its detection could not be used to
modify the actual degree of risk, or likelihood of
contamination. It is also possible to interpret ‘detection’ as
the frequency of monitoring of risks. This interpretation is
incorrect, as frequency of monitoring will not affect
degree of risk; it will only measure the concentration of
microorganisms with more surety. For the reasons
outlined in this paragraph, we consider that the factor
designated ‘likelihood of detection’ should not be used to
assess the ‘risk’ of microbial contamination and Equation
5, an equation without the ‘detection’ variable, used.
Also, if the detection variable is left out, the risk
assessment model will be in agreement with the
fundamental contamination models derived in this paper.
Practical application of models
The authors of this paper have used the models derived in
this paper to assess microbial risk in cleanrooms. Several
cleanrooms have been assessed, and this experience
suggests that risk assessment is best carried out in two
stages. The first stage should be carried out using an
overall risk assessment that allows all of the risks within
the manufacturing suite to be assessed. This can best be
done if a risk assessment, using suitable numerical values
and risk descriptors, is combined with the HACCP system
to give a structured method by which all the microbial
risks are established, assessed, action and alert levels set,
the correct type of monitoring and frequency established,
and the effectiveness of the system verified11.
Use of the overall risk assessment method will
normally demonstrate that the highest risk is at the critical
area, when the product is open and exposed to microbial
contamination. Therefore, it is best to carry out an
additional risk assessment of this critical area. Knowledge
of the fundamental mechanisms of microbial
contamination given in this paper, as well as practical
experience, shows that this must be done by separating
airborne from surface contact contamination. The most
accurate solution is to solve Equations 2 and 4 using
numerical values from every source of contamination in
the cleanroom using each method of transfer. This is
possible with airborne contamination, as the combined
sources of airborne contamination can be measured
adjacent to the product and their deposition calculated, but
it is not possible with surface contact. Information on the
concentration of microbes on surfaces will be available,
Figure 4. Increase in risk caused by an increase in the frequency
and the criticality of an occurrence.
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although almost certainly incomplete, but practically no
information will be available on microbial dispersion,
transfer and deposition, and how frequently it occurs. A
numerical solution is therefore not possible and risk
descriptors that act as surrogates for the required
numerical values should be used. In practical terms this
means that for each stage of production, the concentration
of microbes on the sources, the likelihood of microbial
transfer, the area open to contamination, and the
frequency of occurrence is assessed by the use of suitable
risk factors that may be either numerical values or risk
descriptors. These factors should be combined in a way
that best reflects the contamination models so as to give an
accurate risk rating. Examples of these methods will be
reported in a further article in this journal17.
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